MARKET

MMSI

MMSI

Merit Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

61.53
-0.47
-0.76%
Closed 16:07 06/14 EDT
OPEN
61.90
PREV CLOSE
62.00
HIGH
62.10
LOW
61.33
VOLUME
142.96K
TURNOVER
--
52 WEEK HIGH
65.46
52 WEEK LOW
39.45
MARKET CAP
3.45B
P/E (TTM)
869.07
1D
5D
1M
3M
1Y
5Y
It's Unlikely That Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Will See A Huge Pay Rise This Year
The share price of Merit Medical Systems, Inc. ( NASDAQ:MMSI ) has been growing in the past few years, however, the...
Simply Wall St. · 4d ago
Introducing Merit Medical Systems (NASDAQ:MMSI), The Stock That Zoomed 217% In The Last Five Years
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...
Simply Wall St. · 05/27 10:30
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
Zacks.com · 05/24 14:19
Capital Impact Advisors, LLC Buys Omnicom Group Inc, Service Corp International, Stifel ...
GuruFocus News · 05/19 15:38
Prudent Man Advisors, LLC Buys Becton, Dickinson and Co, Tesla Inc, Customers Bancorp Inc, ...
GuruFocus News · 05/19 09:12
Global Prostatic Arterial Embolization Market: By Analyzing the Performance of Various Competitors 2027 | Merit Medical Systems (MMSI), Boston Scientific (BSX), Mentice (MN2), Siemens Healthineers (SHL)
May 12, 2021 (AmericaNewsHour) -- Research Nester released a report titled "Prostatic Arterial Embolization Market: Global Demand Analysis & Opportunity...
AmericaNewsHour · 05/12 18:19
Procedure Tray Market Key Insights Based on Product Type, End-use and Regional Demand
Japan, Japan, Wed, 12 May 2021 07:58:50 / Comserve Inc. / -- Procedure Tray Market :Global Size, Share, Trends, Forecast, Growth, Key Players, Market...
Comserve · 05/12 12:01
Soft Tissue Biopsy Needles Market Share, Growth, Size, Global Industry Trends, Industry Analysis, Segments, Emerging Technologies, Opportunity and Forecast 2021 to 2028
May 12, 2021 (Market Insight Reports) -- “Soft Tissue Biopsy Needles market (US, Europe, Asia-Pacific) 2021 research includes historical and forecast data,...
Market Insight Reports · 05/12 08:08
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MMSI. Analyze the recent business situations of Merit Med through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MMSI stock price target is 69.78 with a high estimate of 81.00 and a low estimate of 53.00.
EPS
Institutional Holdings
Institutions: 365
Institutional Holdings: 71.55M
% Owned: 127.78%
Shares Outstanding: 56.00M
TypeInstitutionsShares
Increased
67
1.99M
New
30
1.07M
Decreased
97
3.91M
Sold Out
26
300.41K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.36%
Healthcare Equipment & Supplies
+0.39%
Key Executives
Chairman/Director/President/Chief Executive Officer
Fred Lampropoulos
Chief Financial Officer/Treasurer
Raul Parra
Corporate Executive
Justin Lampropoulos
Corporate Executive
Joseph Wright
Chief Operating Officer
Ronald Frost
Chief Human Resource Officer
Michel Voigt
Other
Robert Fredericks
Secretary
Brian Lloyd
Independent Director
A. Scott Anderson
Independent Director
Jill Anderson
Independent Director
Lonny Carpenter
Independent Director
David Floyd
Independent Director
Thomas Gunderson
Independent Director
James Hogan
Independent Director
F. Ann Millner
Independent Director
Lynne Ward
No Data
  • All
  • Financials
  • Insiders
More
About MMSI
Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.

Webull offers kinds of Merit Medical Systems, Inc. stock information, including NASDAQ:MMSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MMSI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MMSI stock methods without spending real money on the virtual paper trading platform.